x
Filter:
Filters applied
- Regular Research Articles
- TGRemove TG filter
- lipid metabolismRemove lipid metabolism filter
- Journal of Lipid ResearchRemove Journal of Lipid Research filter
Publication Date
Please choose a date range between 2021 and 2022.
Author
- Ahmarani, Lena1
- Ahn, in Sook1
- Alabi, Adekunle1
- Auclair, Nickolas1
- Beaulieu, Jean-François1
- Blencowe, Montgomery1
- Cely, Ingrid1
- Chang, Xiaole1
- Dane, Adriaan D1
- Deng, Shijun1
- Geley, Stephan1
- Golderer, Georg1
- Gu, Hong-mei1
- Keller, Markus A1
- Koch, Jakob1
- Lackner, Katharina1
- Levy, Emile1
- Liu, Boyan1
- Luk, Helen1
- Mäkinen, Ville-Petteri1
- Patey, Nathalie1
- Peretti, Noel1
- Pras-Raves, Mia L1
- Qin, Shucun1
- Sailer, Sabrina1
Regular Research Articles
4 Results
- Research ArticleOpen Access
Adaptations of the 3T3-L1 adipocyte lipidome to defective ether lipid catabolism upon Agmo knockdown
Journal of Lipid ResearchVol. 63Issue 6100222Published online: May 7, 2022- Sabrina Sailer
- Katharina Lackner
- Mia L. Pras-Raves
- Eric J.M. Wever
- Jan B. van Klinken
- Adriaan D. Dane
- and others
Cited in Scopus: 0Little is known about the physiological role of alkylglycerol monooxygenase (AGMO), the only enzyme capable of cleaving the 1-O-alkyl ether bond of ether lipids. Expression and enzymatic activity of this enzyme can be detected in a variety of tissues including adipose tissue. This labile lipolytic membrane-bound protein uses tetrahydrobiopterin as a cofactor, and mice with reduced tetrahydrobiopterin levels have alterations in body fat distribution and blood lipid concentrations. In addition, manipulation of AGMO in macrophages led to significant changes in the cellular lipidome, and alkylglycerolipids, the preferred substrates of AGMO, were shown to accumulate in mature adipocytes. - Research ArticleOpen Access
Sar1b mutant mice recapitulate gastrointestinal abnormalities associated with chylomicron retention disease
Journal of Lipid ResearchVol. 62100085Published online: May 5, 2021- Nickolas Auclair
- Alain T. Sané
- Lena Ahmarani
- Nathalie Patey
- Jean-François Beaulieu
- Noel Peretti
- and others
Cited in Scopus: 0Chylomicron retention disease (CRD) is an autosomal recessive disorder associated with biallelic Sar1b mutations leading to defects in intracellular chylomicron (CM) trafficking and secretion. To date, a direct cause-effect relationship between CRD and Sar1b mutation has not been established, but genetically modified animal models provide an opportunity to elucidate unrecognized aspects of these mutations. To examine the physiological role and molecular mechanisms of Sar1b function, we generated mice expressing either a targeted deletion or mutation of human Sar1b using the CRISPR-Cas9 system. - Research ArticleOpen Access
Atherosclerosis-associated hepatic secretion of VLDL but not PCSK9 is dependent on cargo receptor protein Surf4
Journal of Lipid ResearchVol. 62100091Published online: June 9, 2021- Bingxiang Wang
- Yishi Shen
- Lei Zhai
- Xiaodan Xia
- Hong-mei Gu
- Maggie Wang
- and others
Cited in Scopus: 0Plasma LDL is produced from catabolism of VLDL and cleared from circulation mainly via the hepatic LDL receptor (LDLR). Proprotein convertase subtilisin/kexin type 9 (PCSK9) promotes LDLR degradation, increasing plasma LDL-C levels. Circulating PCSK9 is mainly secreted by the liver, whereas VLDL is exclusively secreted by hepatocytes. However, the mechanism regulating their secretion is not completely understood. Surfeit 4 (Surf4) is a cargo receptor localized in the ER membrane. It recruits cargos into coat protein complex II vesicles to facilitate their secretion. - Research ArticleOpen Access
Gene networks and pathways for plasma lipid traits via multitissue multiomics systems analysis
Journal of Lipid ResearchVol. 62100019Published online: January 5, 2021- Montgomery Blencowe
- In Sook Ahn
- Zara Saleem
- Helen Luk
- Ingrid Cely
- Ville-Petteri Mäkinen
- and others
Cited in Scopus: 0Genome-wide association studies (GWASs) have implicated ∼380 genetic loci for plasma lipid regulation. However, these loci only explain 17–27% of the trait variance, and a comprehensive understanding of the molecular mechanisms has not been achieved. In this study, we utilized an integrative genomics approach leveraging diverse genomic data from human populations to investigate whether genetic variants associated with various plasma lipid traits, namely, total cholesterol, high and low density lipoprotein cholesterol (HDL and LDL), and triglycerides, from GWASs were concentrated on specific parts of tissue-specific gene regulatory networks.